Introduction:Basic information about CAS 2898-76-2|Benzamil, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Benzamil |
|---|
| CAS Number | 2898-76-2 | Molecular Weight | 356.21100 |
|---|
| Density | / | Boiling Point | / |
|---|
| Molecular Formula | C13H14ClN7O | Melting Point | / |
|---|
| MSDS | / | Flash Point | / |
|---|
Names
| Name | 3,5-diamino-N-(N'-benzylcarbamimidoyl)-6-chloropyrazine-2-carboxamide |
|---|
| Synonym | More Synonyms |
|---|
Benzamil BiologicalActivity
| Description | Benzamil (Benzylamiloride), an Amiloride analogue, is a Na+/Ca2+ exchanger (NCX) inhibitor (IC50~100 nM). Benzamil also is a non-selective Deg/epithelial sodium channels (ENaC) blocker, and can potentiate myogenic vasoconstriction. Benzamil inhibits TRPP3-mediated Ca2+-activated currents, with an IC50 of 1.1 μM[1][2][3]. |
|---|
| Related Catalog | Signaling Pathways >>Membrane Transporter/Ion Channel >>Sodium Channel |
|---|
| In Vitro | Benzamil (Benzylamiloride) inhibits neuronal and heterologously expressed small conductance Ca2+-activated K2+ channels[4]. |
|---|
| In Vivo | Benzamil (Benzylamiloride) (0.7 mg/kg/day; s.c.) treated stroke-prone spontaneously hypertensive rats (SHRSP) survived, on average, until 16.1 weeks of age in SHRSP rats[5]. |
|---|
| References | [1]. Fischer KG, et al. Characterization of a Na(+)-Ca(2+) exchanger in podocytes. Nephrol Dial Transplant. 2002 Oct;17(10):1742-50. [2]. Wang X, et al. Effects of amiloride, benzamil, and alterations in extracellular Na+ on the rat afferent arteriole and its myogenic response. Am J Physiol Renal Physiol. 2008 Jul;295(1):F272-82. [3]. Dai XQ, et al. Inhibition of TRPP3 channel by amiloride and analogs. Mol Pharmacol. 2007 Dec;72(6):1576-85. [4]. Castañeda MS, et al. Benzamil inhibits neuronal and heterologously expressed small conductance Ca2+-activated K+channels. Neuropharmacology. 2019 Nov 1;158:107738. [5]. Teiwes J, et al. Epithelial sodium channel inhibition in cardiovascular disease. A potential role for amiloride. Am J Hypertens. 2007 Jan;20(1):109-17. |
|---|
Chemical & Physical Properties
| Molecular Formula | C13H14ClN7O |
|---|
| Molecular Weight | 356.21100 |
|---|
| Exact Mass | 355.07200 |
|---|
| PSA | 145.30000 |
|---|
| LogP | 3.59470 |
|---|
| InChIKey | KXDROGADUISDGY-UHFFFAOYSA-N |
|---|
| SMILES | NC(=NCc1ccccc1)NC(=O)c1nc(Cl)c(N)nc1N |
|---|
| Storage condition | 2-8°C |
|---|
Safety Information
| Hazard Codes | Xi |
|---|
| Risk Phrases | 36/37/38 |
|---|
| Safety Phrases | 26-36 |
|---|
| RIDADR | UN 2811 |
|---|
| HS Code | 2934999090 |
|---|
Customs
| HS Code | 2934999090 |
|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|---|
Synonyms
| GNF-Pf-192 |
| Benzamil |
| 3,5-diamino-6-chloro-pyrazine-2-carboxylic acid benzylcarbamimidoyl-amide |